selected scholarly activity
-
books
-
chapters
- Safe Prescription of NSAIDs in Clinical Practice. 91-104. 2016
- Randomized Controlled Trials. 113-118. 2014
- Treatment of non-NSAID and non-H. pylori gastroduodenal ulcers and hypersecretory states. 315-336. 2006
- Treatment of non-NSAID and non-H. pylori gastroduodenal ulcers and hypersecretory states. 315-336. 2005
-
conferences
- Evaluation of a Novel, Icon-Based Symptom Assessment Tool for Gastroenterology. American Journal of Gastroenterology. S754-S755. 2015
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report. Gut. 646-664. 2012
- Risk of Serious Upper Gastrointestinal (UGI) Complications With use of Non-Selective (NS) NSAIDs for at Least 4 Weeks Among Patients With a History of Peptic Ulcer (PU) or PU Complications: A Series of Systematic Reviews and Meta-Analyses. Gastroenterology. S501-S501. 2012
- Helicobacter pylori Eradication and Change in Body Weight: A Systematic Review. Gastroenterology. S734-S734. 2011
- Helicobacter pylori eradication reduces the incidence of gastric cancer: Results of a systematic review of randomized controlled trials. Gastroenterology. A631-A632. 2008
- Non-Erosive Reflux Disease – Defining the Entity and Delineating the Management. Digestion. 1-5. 2008
- Is There a Difference in the Prevalence of Helicobacter pylori Infection between Short-Segment and Long-Segment Barrettʼs Esophagus?. American Journal of Gastroenterology. S134-S134. 2007
- GERD. Journal of Clinical Gastroenterology. S72-S80. 2007
- Whistler Consensus. Journal of Clinical Gastroenterology. S47-S50. 2007
- Whistler Meeting. Journal of Clinical Gastroenterology. S45-S46. 2007
- Hemoclip for Peptic Ulcer Bleeding, a Meta-Analysis of Randomized Controlled Trials. Gastrointestinal Endoscopy. AB365-AB365. 2007
- Review article: the risks of oesophageal acid exposure ‐ from minimal mucosal changes to malignancy. Alimentary Pharmacology and Therapeutics Symposium Series. 15-22. 2007
- Controversial issues on Helicobacter pylori (Debates): Hp and pH (Con). Helicobacter. 6-7. 2006
- Helicobacter pylori treatment guidelines and impact on health care: A North American perspective. Helicobacter. 11-12. 2006
- Novel approach to eradication of Helicobacter pylori: Carbonic anhydrase inhibition interferes with acid acclimatization, studies in vitro and in vivo. Helicobacter. 388-388. 2006
- Th1 Cytokines and reduced expression of EP3 receptors may facilitate Helicobacter pylori-induced corpus gastritis and atrophy. Helicobacter. 349-350. 2006
- Long-term Helicobacter pylori infection of Outbred North American Mongolian gerbils in conjunction with high salt diet does not result in gastric cancer - Revisiting the model. Helicobacter. 505-505. 2005
- Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004. Canadian Journal of Gastroenterology and Hepatology. 15-35. 2005
- Can Canadian endoscopists predict lesions at uper Gi endoscopy (EGD)? An evaluation of the 'PAGE' program. Gastroenterology. A353-A354. 2003
- Practice audit in gastroenterology - The PAGE program or upper GI endoscopy (EGD). Gastroenterology. A353-A353. 2003
- Socioeconomic burden of digestive disorders in Canada: A retrospective and descriptive analysis. Gastroenterology. A166-A166. 2003
- Synergy of high salt diet and infection with the sydney strain of Helicobacter pylori infection results in gastric mucosal dysplasia in mongolian gerbils. Gastroenterology. A595-A595. 2003
- The evolving epidemiology of Helicobacter pylori infection and gastric cancer. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2002. 177-183. 2003
- Non-Steroidal Anti-Inflammatory Drug (NSAID) use and prevention of Colorectal Cancer (CRC): a meta-analysis. American Journal of Gastroenterology. S232-S233. 2002
- Effect of high salt diet on the colonization and pathological changes of gastric mucosa in Mongolian gerbils infected with the Sydney strain of Helicobacter pylori. Gastroenterology. A422-A422. 2002
- A multi-laboratory comparison of proficiency in testing susceptibility of Helicobacter pylori, and correlation between agar dilution and E test methods. Gut. A85-A85. 2001
- Follow-up endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by H. pylori status. Bone. S222-S222. 2001
- Carbon dioxide (CO2) vs room air (RA) insufflation for colonoscopy: A randomized double-blind controlled trial.. Gastrointestinal Endoscopy. AB76-AB76. 2001
- The host specific differences in physiology of acid secretion related to prostaglandins may bias toward Helicobacter related mucosal injury.. Gastroenterology. A649-A649. 2001
- Bismuth-based Helicobacter pylori (Hp) therapy by a single capsule [(Bismuth subcitrate (B) plus metronidazole (M) plus tetracycline (T)] plus omeprazole (O) vs O plus amoxicillin (A) plus clarithromycin (C): An interim analysis.. Gut. A100-A100. 2000
- Effect of purified forms of lipopolysaccharide from various strains of Helicobacter pylori and Helicobacter felis on acid secretion in vitro. Gastroenterology. A733-A733. 2000
- Endoscopy study comparing risedronate andalendronate in postmenopausal women. Gastroenterology. A474-A474. 2000
- Role of Helicobacter pylori infection in NSAID-associated gastropathy. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000. 443-451. 2000
- Bismuth-based quadruple therapy with colloidal bismuth subcitrate plus tetracycline plus metronidazole (M) plus omeprazole in eradication of M sensitive and M resistant Helicobacter pylori. Gastroenterology. A227-A227. 1999
- Differential effect of Th1 vs Th2 cytokines on acid secretion in mouse gastric glands: Possible significance in Helicobacter infection?. Gastroenterology. A611-A611. 1999
- A systematic overview of the use of diary cards, quality of life questionnaires and psychometric tests in the treatment trails of Helicobacter pylori positive and negative non-ulcer dyspepsia. Gastroenterology. A275-A275. 1998
- Immunomodulation of Helicobacter felis colonization of the mouse stomach. Gastroenterology. A935-A935. 1998
- An overview of Helicobacter pylori epidemiology studies. HELICOBACTER PYLORI. 295-307. 1998
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology. 1069-1077. 1997
- One week clarithromycin 500 mg bid is better than 250 mg bid for eradicating Helicobacter pylori (H pylori) infection when combined with proton pump inhibitor (P) and metronidazole (M) or amoxicillin (A): A meta-analysis. Gastroenterology. A153-A153. 1997
- Which combination therapy can eradicate >=90% Helicobacter pylori (H-pylori) infection?: A meta-analysis of amoxicillin, metronidazole, tetracycline and clarithromycin containing regimens.. Gastroenterology. A19-A19. 1997
- Clinical Expressions of Helicobacter pylori Infection. American Journal of Medicine. 27S-34S. 1996
- Defining Helicobacter pylori as a Pathogen: Strain Heterogeneity and Virulence. American Journal of Medicine. 2S-11S. 1996
- Helicobacter pylori and Complicated Ulcer Disease. American Journal of Medicine. 52S-59S. 1996
- Helicobacter pylori and Ulcerogenesis. American Journal of Medicine. 19S-26S. 1996
- Testing for Helicobacter pylori in Clinical Practice. American Journal of Medicine. 35S-41S. 1996
- The Economics of Eradicating Helicobacter pylori Infection in Duodenal Ulcer Disease. American Journal of Medicine. 60S-64S. 1996
- Transmission and Epidemiology of Helicobacter pylori. American Journal of Medicine. 12S-18S. 1996
- Do younger patients with Helicobacter pylori (HP) infection have a higher risk of gastric cancer? A meta analysis of the relationship between HP seropostivity and gastric cancer (GC). Gastroenterology. A532-A532. 1996
- The diagnosis of Helicobacter pylori infection in a tertiary care centre by detection of salivary antibodies. Gastroenterology. A178-A178. 1996
- Economic evaluation of Helicobacter pylori eradication in the management of duodenal ulcer. HELICOBACTER PYLORI. 384-397. 1996
- Helicobacter pylori and dyspepsia: A conceptual approach. HELICOBACTER PYLORI. 324-339. 1996
- COST-EFFECTIVENESS OF HELICOBACTER-PYLORI (HELICOBACTER-PYLORI) ERADICATION IN THE LONG-TERM MANAGEMENT OF DUODENAL-ULCER. Gastroenterology. A27-A27. 1995
- PROTRACTED GASTRIC-ACID SECRETION IN HELICOBACTER-PYLORI POSITIVE DU PATIENTS FOLLOWING ERADICATION. Gastroenterology. A122-A122. 1995
- THE EFFECT OF ERADICATION OF HELICOBACTER-PYLORI (HP) ON SYMPTOMS OF NONULCER DYSPEPSIA (NUD) - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. Gastroenterology. A250-A250. 1995
- Dynamic analysis of area under the curve (AUC) estimation of hydrogen ion activity predicts mucosal damage in GERD. Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings. 1174-1176. 1994
- DUODENAL-ULCER RECURRENCE AFTER HELICOBACTER-PYLORI (HP) ERADICATION - A METAANALYSIS. Gastroenterology. A142-A142. 1994
- ERADICATION OF HELICOBACTER-PYLORI (HP) - A METAANALYSIS. Gastroenterology. A142-A142. 1994
- REDUCED GASTRIC-ACID SECRETION IN THE HELICOBACTER-FELIS-INFECTED MOUSE. Gastroenterology. A739-A739. 1994
- SHORT-TERM EFFECT ON ACID SECRETORY RESPONSE AND PARIETAL-CELL SENSITIVITY IN HELICOBACTER-PYLORI POSITIVE DU PATIENTS FOLLOWING ERADICATION. Gastroenterology. A100-A100. 1994
- CYTOKINES AND PEPTIC-ULCER DISEASE. European Journal of Gastroenterology and Hepatology. S69-S73. 1993
- THE POTENTIAL ROLE OF GASTRIC EPITHELIUM IN NEUTROPHIL RECRUITMENT, ATTACHMENT AND ANTIGEN PRESENTATION DURING HELICOBACTER-PYLORI INFECTION. Journal of Immunology. A10-A10. 1993
- DOES RAPID HEALING OF PEPTIC-ULCER PREDISPOSE TO EARLIER RELAPSE. Gastroenterology. A35-A35. 1993
- GASTRIC-JUICE IMMUNOGLOBULINS - IMMUNOPHYSIOLOGICAL INTERACTION IN HELICOBACTER-PYLORI INFECTION. Gastroenterology. A176-A176. 1993
- INTERLEUKIN-8 SECRETION BY GASTRIC EPITHELIUM FOLLOWING HELICOBACTER-PYLORI INFECTION INVITRO. Gastroenterology. A687-A687. 1993
- NSAID AND PEPTIC-ULCER THERAPY IN PATIENTS WITH GASTRODUODENAL ULCER (GU DU). Gastroenterology. A150-A150. 1993
- PARIETAL-CELL SENSITIVITY - THE EFFECTS OF ERADICATING HELICOBACTER-PYLORI IN DU PATIENTS VS NORMAL VOLUNTEERS (NV). Gastroenterology. A53-A53. 1993
- Current research and future directions in peptic ulcer research. Journal of Tokyo Women's Medical College. 21-27. 1993
- Hp and pH: Implications for the Eradication of Heliobacter pylori. Canadian Journal of Gastroenterology and Hepatology. 406-410. 1993
- Canadian Consensus Conference on the Treatment of Gastroesophageal Reflux Disease. Canadian Journal of Gastroenterology and Hepatology. 277-289. 1992
- Discussion Acid Suppression for the Long-Term Management of Reflux Disease. Part 2. Digestion. 68-69. 1992
- Discussion Practical Considerations Regarding Long-Term Treatment with Omeprazole. Digestion. 120-121. 1992
- ERADICATION OF HELICOBACTER-PYLORI - METAANALYSIS TO DETERMINE OPTIMAL THERAPY. Gut. A1220-A1220. 1991
- APPLICATIONS AND PITFALLS OF ENDOSCOPY IN INFLAMMATORY BOWEL-DISEASE. TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY. 101-113. 1991
- HISTAMINE-RECEPTORS IN CANINE GASTRIC AND COLONIC MUSCULARIS MUCOSAE. Gut. A1179-A1180. 1990
- Applications and Pitfalls of Endoscopy in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology. 324-330. 1990
- Chairman’s Summary. Digestion. 82-83. 1990
- NSAID-Induced Gastric Ulcers: Exploring the Silent Dilemma. Canadian Journal of Gastroenterology and Hepatology. 89-90. 1990
- Potent acid suppression and relationship to duodenal ulcer healing. Round Table Series - Royal Society of Medicine. 66-75. 1990
- PATIENTS PREFERENCE FOR COLONOSCOPY OR FLEXIBLE SIGMOIDOSCOPY PLUS BARIUM ENEMA. Gastrointestinal Endoscopy. 211-211. 1988
- COLONOSCOPY OR BARIUM ENEMA - WHICH WOULD YOU RATHER. American Journal of Gastroenterology. 958-958. 1987
- FLEXIBLE SIGMOIDOSCOPY (S) PLUS DOUBLE CONTRAST BARIUM ENEMA (DCBE) VS COLONOSCOPY (CS) IN RECTAL BLEEDING. Gastroenterology. 1448-1448. 1987
- A COMPARISON OF COSTS OF PERFORMING DOUBLE CONTRAST BARIUM ENEMA PLUS FLEXIBLE SIGMOIDOSCOPY VS COLONOSCOPY TO EXAMINE THE LARGE-BOWEL. Gastroenterology. 1472-1472. 1986
- COMPARED COSTS OF COLONIC IMAGING - BARIUM ENEMA PLUS FLEXIBLE SIGMOIDOSCOPY VS COLONOSCOPY. Clinical and Investigative Medicine. A47-A47. 1986
- COLONIC PERMEABILITY TO CR-51-EDTA IN INFLAMMATORY BOWEL-DISEASE. Gut. 1123-1123. 1985
- EARLY DIAGNOSIS OF COLORECTAL NEOPLASIA USING HEMOCCULT TESTING IN GENERAL-PRACTICE. American Journal of Gastroenterology. 856-856. 1985
- Colorectal spirochetosis: report of 3 cases. Clinical Biochemistry. 212-213. 1984
- A COMPUTERIZED SYSTEM FOR COLONOSCOPY RECORDS - APPLICATION IN A SURVEY OF COLORECTAL NEOPLASIA. Diseases of the Colon and Rectum. 576-577. 1984
- HEMOCCULT TESTING IN GENERAL-PRACTICE FOR EARLY DIAGNOSIS OF COLORECTAL-CANCER. Gut. A561-A561. 1984
- A COMPUTERIZED SYSTEM FOR COLONOSCOPY RECORDS. American Journal of Gastroenterology. 685-685. 1983
- ABNORMAL COLONIC MOTILITY IN PNEUMATOSIS CYSTOIDES INTESTINALIS. Gastroenterology. 1128-1128. 1983
- PROGNOSIS OF COLONIC CARCINOMAS DIAGNOSED BY COLONOSCOPY. Gut. A454-A454. 1980
- COLONOSCOPY FOR UNEXPLAINED RECTAL BLEEDING. Gastroenterology. 1158-1158. 1979
- COLONOSCOPY FOR UNEXPLAINED RECTAL BLEEDING. Gut. 823-823. 1976
-
journal articles
- Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments. Current Gastroenterology Reports. 26:273-293. 2024
- Mathematical model of the relationship between pH holding time and erosive esophagitis healing rates.. CPT: Pharmacometrics and Systems Pharmacology. 2024
- <i>Helicobacter pylori</i> Infection: A 40-Year Journey through Shifting the Paradigm to Transforming the Management. Digestive Diseases. 42:299-308. 2024
- A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics. 58:16-25. 2023
- Helicobacter pylori World Gastroenterology Organization Global Guideline. Journal of Clinical Gastroenterology. 57:111-126. 2023
- Editorial: slow progress to optimising H. pylori eradication treatment with antisecretory drugs. Alimentary Pharmacology and Therapeutics. 56:1074-1075. 2022
- Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report. Gut. 71:1724-1762. 2022
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. Digestive Diseases. 39:119-139. 2021
- Editorial: acid suppression with potassium‐competitive acid blockers dismissing genotype concerns. Alimentary Pharmacology and Therapeutics. 53:187-188. 2021
- Gastrointestinal pharmacology: practical tips for the esophagologist. Annals of the New York Academy of Sciences. 1481:90-107. 2020
- Helicobacter pylorieradication for the prevention of gastric neoplasia. Cochrane Database of Systematic Reviews. 7:CD005583. 2020
- Editorial: potassium‐competitive acid blockers for acid‐related diseases—tegoprazan, a new kid on the block. Alimentary Pharmacology and Therapeutics. 50:960-962. 2019
- The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Current Opinion in Gastroenterology. 35:344-355. 2019
- Potent Acid Suppression with PPIs and P-CABs: What’s New?. Current Treatment Options in Gastroenterology. 16:570-590. 2018
- Recent advances in Barrett's esophagus. Annals of the New York Academy of Sciences. 1434:227-238. 2018
- Non-variceal upper gastrointestinal bleeding. Nature Reviews Disease Primers. 4:18020. 2018
- Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. The Lancet Gastroenterology and Hepatology. 3:231-241. 2018
- Communicating Gastrointestinal Symptoms: The Patient’s Challenge. Critical Reviews in Biomedical Engineering. 46:83-92. 2018
- Effect of Aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E2 and thromboxane A2 levels in the anaesthetized rats in vivo. Molecular and Cellular Biochemistry. 438:25-34. 2018
- Gastric Cancer as Preventable Disease. Clinical Gastroenterology and Hepatology. 15:1833-1843. 2017
- World Gastroenterology Organisation Global Guidelines. Journal of Clinical Gastroenterology. 51:467-478. 2017
- The Esophageal and Gastric Microbiome in Health and Disease. Gastroenterology Clinics of North America. 46:121-141. 2017
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report. Gut. 66:6-30. 2017
- Reply. Gastroenterology. 152:303-304. 2017
- What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis. World Journal of Gastroenterology. 23:2435-2435. 2017
- Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?. Gastroenterology. 151:222-225. 2016
- The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 151:51-69.e14. 2016
- Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Medicine. 13:55. 2015
- Editorial: towards extended acid suppression - the search continues. Alimentary Pharmacology and Therapeutics. 42:1027-1029. 2015
- Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?. Clinical and Translational Gastroenterology. 6:e119-e119. 2015
- The stomach in health and disease. Gut. 64:1650-1668. 2015
- Helicobacter pylorieradication for the prevention of gastric neoplasia. Clinical Respiratory Journal. 2015:CD005583. 2015
- Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges. Clinics in Laboratory Medicine. 34:787-798. 2014
- Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical need. Alimentary Pharmacology and Therapeutics. 40:987-989. 2014
- Coping With Common Gastrointestinal Symptoms in the Community. Journal of Clinical Gastroenterology. 48:567-578. 2014
- Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. The BMJ. 348:g3174-g3174. 2014
- Commentary: independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer. Alimentary Pharmacology and Therapeutics. 39:993-994. 2014
- Canadian Association of Gastroenterology Position Statement: Fecal Microbiota Transplant Therapy. Canadian Journal of Gastroenterology and Hepatology. 28:66-68. 2014
- Navigating Long-Term Safety in Fecal Microbiota Transplantation. American Journal of Gastroenterology. 108:1538-1538. 2013
- A presentation of latent tropical sprue in a Canadian hospital. European Journal of Gastroenterology and Hepatology. 25:996-1000. 2013
- Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 108:500-508. 2013
- The impact of intensifying acid suppression on sleep disturbance related to gastro‐oesophageal reflux disease in primary care. Alimentary Pharmacology and Therapeutics. 37:730-737. 2013
- WDHD 2012 Summary and a Glimpse into 2013. Journal of Clinical Gastroenterology. 46:i-iii. 2012
- World Gastroenterology Organisation Global Guidelines on Obesity. Journal of Clinical Gastroenterology. 46:555-561. 2012
- World Digestive Health Day 2012. Journal of Clinical Gastroenterology. 46:i-ii. 2012
- Advances in understanding inflammation in esophageal disease. Frontiers of Gastrointestinal Research. 30:142-147. 2012
- A Global Perspective on Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 46:356-366. 2012
- Acid Suppression for Reflux Disease: “Off-the-Peg” or a Tailored Approach?. Clinical Gastroenterology and Hepatology. 10:210-213. 2012
- Altered physiology of acid secretion in depression‐prone Flinders rats results in exacerbated NSAID and stress‐induced gastric damage. Neurogastroenterology and Motility. 24:154-154. 2012
- Helicobacter pylori and immigrant health. CANADIAN MEDICAL ASSOCIATION JOURNAL. 184:74.3-75. 2012
- Helicobacter pyloriin First Nations and Recent Immigrant Populations in Canada. Canadian Journal of Gastroenterology and Hepatology. 26:97-103. 2012
- Advances in Understanding Inflammation in Esophageal Disease. Frontiers of Gastrointestinal Research. 30:142-147. 2012
- Spontaneous autoimmune gastritis and hypochlorhydria are manifest in the ileitis-prone SAMP1/YitFcs mice. American Journal of Physiology - Gastrointestinal and Liver Physiology. 302:G105-G115. 2012
- World Gastroenterology Organisation Global Guidelines: Helicobacter pylori in developing countries August 2010. South African Gastroenterology Review. 9:16-22. 2011
- Barrett's esophagus: proton pump inhibitors and chemoprevention II. Annals of the New York Academy of Sciences. 1232:114-139. 2011
- Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg. Alimentary Pharmacology and Therapeutics. 33:1177-1179. 2011
- World Gastroenterology Organisation Global Guideline. Journal of Clinical Gastroenterology. 45:383-388. 2011
- Erratum to: Novel Approaches to Inhibition of Gastric Acid Secretion. Current Gastroenterology Reports. 13:110-110. 2011
- Acid-NSAID/Aspirin Interaction in Peptic Ulcer Disease. Digestive Diseases. 29:465-468. 2011
- Novel Approaches to Inhibition of Gastric Acid Secretion. Current Gastroenterology Reports. 12:437-447. 2010
- The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial. American Journal of Gastroenterology. 105:2341-2346. 2010
- Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention. Gastroenterology Clinics of North America. 39:433-464. 2010
- Preface. Gastroenterology Clinics of North America. 39:xv-xvi. 2010
- Proton pump inhibitor and clopidogrel interaction: The case for watchful waiting. Journal of Gastroenterology and Hepatology. 25:1342-1347. 2010
- Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation. Rheumatology. 49:837-843. 2010
- Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. European Journal of Gastroenterology and Hepatology. 22:583-590. 2010
- Is There an Increased Risk of GERD After Helicobacter pylori Eradication?: A Meta-Analysis. American Journal of Gastroenterology. 105:1007-1013. 2010
- The pharmacodynamics and pharmacokinetics of S‐tenatoprazole‐Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects. Alimentary Pharmacology and Therapeutics. 31:648-657. 2010
- International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding. ACP journal club. 152:101-101. 2010
- Inaccurate endoscopy: a better explanation for placebo‐associated endoscopic ulcers: authors’ reply. Alimentary Pharmacology and Therapeutics. 30:957-960. 2009
- Response to Fuccio et al.. American Journal of Gastroenterology. 104:2853-2854. 2009
- Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology. 24:1587-1600. 2009
- Endoscopy of the esophagus in gastroesophageal reflux disease: are we losing sight of symptoms? Another perspective. Gullet. 22:461-466. 2009
- Meta‐analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo‐controlled NSAID trials. Alimentary Pharmacology and Therapeutics. 30:197-209. 2009
- Evolving issues in the management of reflux disease?. Current Opinion in Gastroenterology. 25:342-351. 2009
- Systematic Reviews: The Good, the Bad and the Ugly. American Journal of Gastroenterology. 104:1086-1092. 2009
- Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Alimentary Pharmacology and Therapeutics. 29:481-496. 2009
- Helicobacter pylori Infection and Barrett's Esophagus: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 104:492-500. 2009
- Diagnosis and Management of Non-Erosive Reflux Disease – The Vevey NERD Consensus Group. Digestion. 80:74-88. 2009
- Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines. Digestion. 80:226-234. 2009
- Myths and facts in the use of anti-inflammatory drugs. Annals of Medicine. 41:423-437. 2009
- A BALANCING VIEW: Evidence-Based Medicine: Neither Savior Nor Scourge but a Practical Tool for Clinical Practice. American Journal of Gastroenterology. 103:2969-2971. 2008
- Medical Management of Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America. 37:879-899. 2008
- Proton pump inhibitors: the beginning of the end or the end of the beginning?. Current Opinion in Pharmacology. 8:677-684. 2008
- Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint. Cancer Epidemiology, Biomarkers and Prevention. 17:1858-1861. 2008
- Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials. Gastrointestinal Endoscopy. 68:339-351. 2008
- Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904‐Z. Alimentary Pharmacology and Therapeutics. 28:187-199. 2008
- Re-analysis of application of haemoclips for non-variceal upper gastrointestinal bleeding data.. Gut. 57:1023-1024. 2008
- Asia–Pacific consensus guidelines on gastric cancer prevention. Journal of Gastroenterology and Hepatology. 23:351-365. 2008
- Can global guidelines change health policy?. Nature Reviews Gastroenterology and Hepatology. 5:120-121. 2008
- Corrigendum. Journal of Gastroenterology and Hepatology. 23:504-504. 2008
- Is an evidence-based approach to creating guidelines always the right one?. Nature Reviews Gastroenterology and Hepatology. 5:60-61. 2008
- New algorithm for the treatment of gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 27:249-256. 2008
- Access to Specialist Gastroenterology Care in Canada: Comparison of Wait Times and Consensus Targets. Canadian Journal of Gastroenterology and Hepatology. 22:161-167. 2008
- Access to Specialist Gastroenterology Care in Canada: The Practice Audit in Gastroenterology (PAGE) Wait Times Program. Canadian Journal of Gastroenterology and Hepatology. 22:155-160. 2008
- Are global guidelines desirable, feasible and necessary?. Nature Reviews Gastroenterology and Hepatology. 5:2-3. 2008
- Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update. Journal of Gastroenterology and Hepatology. 23:8-22. 2008
- Precise Role of Acid in Non-Erosive Reflux Disease. Digestion. 78:31-41. 2008
- Global Gastrointestinal Safety Profile of Etoricoxib and Lumiracoxib. Current Pharmaceutical Design. 13:2237-2247. 2007
- The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis. American Journal of Gastroenterology. 102:1789-1798. 2007
- Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?. Canadian Family Physician. 53:1177-1184. 2007
- Whistler Summary: “The Slow Rate of Rapid Progress”. Journal of Clinical Gastroenterology. 41:539-545. 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 56:772-781. 2007
- Current concepts in the management of helicobacter pylori infection - The maastricht III consensus report. Chinese Journal of Gastroenterology. 12:159. 2007
- Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. International Journal of Clinical Pharmacology and Therapeutics. 45:188-188. 2007
- GERD Evaluation. Journal of Clinical Gastroenterology. 41:237-241. 2007
- Prevalence, Impact and Attitudes Toward Lower Gastrointestinal Dysmotility and Sensory Symptoms, and Their Treatment in Canada: A Descriptive Study. Canadian Journal of Gastroenterology and Hepatology. 21:31-37. 2007
- Acetaminophen and Aminotransferase Elevations. Journal of the American Medical Association (JAMA). 296:2798-2798. 2006
- Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin. Clinical Gastroenterology and Hepatology. 4:1082-1089.e4. 2006
- Selective Serotonin Reuptake Inhibitors and Risk of Upper GI Bleeding: Confusion or Confounding?. American Journal of Medicine. 119:719-727. 2006
- The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis. American Journal of Gastroenterology. 101:1467-1475. 2006
- Healing rates for moderate and severe oesophagitis: author's reply. Alimentary Pharmacology and Therapeutics. 23:1374-1375. 2006
- Levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence?. Alimentary Pharmacology and Therapeutics. 23:1283-1285. 2006
- Peptic ulcer disease today. Nature Reviews Gastroenterology and Hepatology. 3:80-89. 2006
- Practice Audit in Gastroenterology (Page) Program: A Novel Approach to Continuing Professional Development. Canadian Journal of Gastroenterology and Hepatology. 20:405-410. 2006
- Prevention of anti‐inflammatory drug‐induced gastrointestinal damage: Benefits and risks of therapeutic strategies. Annals of Medicine. 38:415-428. 2006
- Cimetidine or vagotomy?. British Journal of Surgery. 71:402-403. 2005
- Cimetidine or vagotomy? Comparison of the effects of proximal gastric vagotomy, cimetidine and placebo on nocturnal intragastric acidity and acid secretion in patients with cimetidine resistant duodenal ulcer. British Journal of Surgery. 70:704-706. 2005
- Colonoscopy in the management of colon polyps. British Journal of Surgery. 61:673-682. 2005
- Proximal gastric vagotomy versus truncal vagotomy and antrectomy. British Journal of Surgery. 71:570-571. 2005
- Review article: the unmet needs in delayed‐release proton‐pump inhibitor therapy in 2005. Alimentary Pharmacology and Therapeutics. 22:10-19. 2005
- Time Course and Pattern of Blood Loss With Ibuprofen Treatment in Healthy Subjects. Clinical Gastroenterology and Hepatology. 3:1075-1082. 2005
- Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers. American Journal of Gastroenterology. 100:1949-1956. 2005
- Host-specific differences in the physiology of acid secretion related to prostaglandins may play a role in gastric inflammation and injury. American Journal of Physiology - Gastrointestinal and Liver Physiology. 288:G1110-G1117. 2005
- Canadian Helicobacter Study Group Consensus Conference: Update on the Approach to Helicobacter Pylori Infection in Children and Adolescents – an Evidence-Based Evaluation. Canadian Journal of Gastroenterology and Hepatology. 19:399-408. 2005
- Do patients with non-ulcer dyspepsia respond differently toHelicobacter pylorieradication treatments from those with peptic ulcer disease? A systematic review. World Journal of Gastroenterology. 11:2726-2726. 2005
- Doctor–patient interaction for irritable bowel syndrome in primary care. European Journal of Gastroenterology and Hepatology. 16:1161-1166. 2004
- Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?. American Journal of Medicine. 117:86-91. 2004
- Helicobacter pylori Public Health Implications. Helicobacter. 9:67-72. 2004
- Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands. Gut. 53:1075-1081. 2004
- Helicobacter pylori and gastric cancer. Gastroenterology. 126:1927-1927. 2004
- Reply. Gastroenterology. 126:1927-1928. 2004
- Report of the Asia–Pacific consensus on the management of gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology. 19:357-367. 2004
- Should NSAID/low‐dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing. Alimentary Pharmacology and Therapeutics. 19:9-16. 2004
- Helicobacter pylori and the Prevention of Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology. 18:295-302. 2004
- A response to Farup and Bytzer. Scandinavian Journal of Gastroenterology, Supplement. 39:803-804. 2004
- Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on Colon Cancer Screening. Canadian Journal of Gastroenterology and Hepatology. 18:93-99. 2004
- Canadian Helicobacter Study Group Consensus Conference: Update on the Management ofHelicobacter pylori- An Evidence-Based Evaluation of Six Topics Relevant to Clinical Outcomes in Patients Evaluated forH pyloriInfection. Canadian Journal of Gastroenterology and Hepatology. 18:547-554. 2004
- Establishment of T‐Helper‐2 immune response based gerbil model of enteric infection. Scandinavian Journal of Gastroenterology, Supplement. 39:668-673. 2004
- Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?. Inflammopharmacology. 11:337-354. 2003
- Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 125:1636-1644. 2003
- Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 125:1636-1644. 2003
- Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods. Antimicrobial Agents and Chemotherapy. 47:3138-3144. 2003
- The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. American Journal of Gastroenterology. 98:1725-1733. 2003
- The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. American Journal of Gastroenterology. 98:1725-1733. 2003
- Has education about Helicobacter pylori infection been effective? Worldwide survey of primary care physicians. Journal of Gastroenterology and Hepatology. 18:512-520. 2003
- Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: a Prospective, Randomized, Multicenter, North American Trial. American Journal of Gastroenterology. 98:562-567. 2003
- Letter. Gastrointestinal Endoscopy. 57:436-437. 2003
- The use of CO2 in colonoscopy - Response. Gastrointestinal Endoscopy. 57:437-438. 2003
- Helicobacter pylori Twenty Years on…. Canadian Journal of Gastroenterology and Hepatology. 17:7B. 2003
- Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib. Alimentary Pharmacology and Therapeutics. 17:201-210. 2003
- Complementary studies of the gastrointestinal safety of the cyclo‐oxygenase‐2‐selective inhibitor etoricoxib. Alimentary Pharmacology and Therapeutics. 17:201-210. 2003
- Motion-Cyclo-oxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs are as Safe as Placebo for the Stomach: Arguments for the Motion. Canadian Journal of Gastroenterology and Hepatology. 17:339-341. 2003
- The Evolving Epidemiology of Helicobacter pylori Infection and Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology. 17:18B-20B. 2003
- Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments. Best Practice and Research in Clinical Gastroenterology. 16:869-883. 2002
- Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.. Canadian Journal of Cardiology. 18:1301-1308. 2002
- 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.. Journal of Rheumatology. 29:1965-1974. 2002
- Re: Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: defining the role of the gastroprotective agents.. Canadian Journal of Gastroenterology and Hepatology. 16:651. 2002
- Minimizing postcolonoscopy abdominal pain by using CO insufflation: A prospective, randomized, double blind, controlled trial evaluating a new commercially available CO delivery system. Gastrointestinal Endoscopy. 56:190-194. 2002
- Evolving Concepts in the Pathophysiology of Functional Gastrointestinal Disorder. Journal of Clinical Gastroenterology. 35:S2-S6. 2002
- Editorial: Uses and abuses of meta-analysis in gastroenterology. Journal of Digestive Diseases. 3:39-42. 2002
- Helicobacter pylori and peptic-ulcer disease. The Lancet. 359:1944-1944. 2002
- Helicobacter pylori and peptic-ulcer disease. The Lancet. 359:1943-1943. 2002
- Acid suppression in healthy subjects following lansoprazole or pantoprazole. Alimentary Pharmacology and Therapeutics. 16:425-433. 2002
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report. Alimentary Pharmacology and Therapeutics. 16:167-180. 2002
- Etiology of Dyspepsia: Implication for Empiric Therapy. Canadian Journal of Gastroenterology and Hepatology. 16:635-641. 2002
- Recommendations for the Appropriate Use of Anti-Inflammatory Drugs in the Era of the Coxibs: Defining the Role of Gastroprotective Agents. Canadian Journal of Gastroenterology and Hepatology. 16:231-240. 2002
- Risks and Benefits ofHelicobacter pyloriEradication: Current Status. Canadian Journal of Gastroenterology and Hepatology. 16:57-62. 2002
- Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. The Lancet. 359:14-22. 2002
- Uses and abuses of meta-analysis in gastroenterology. Chinese Journal of Gastroenterology. 7:67-69. 2002
- Effect of Purified Lipopolysaccharides from Strains of Helicobacter pylori and Helicobacter felis on Acid Secretion in Mouse Gastric Glands In Vitro. Infection and Immunity. 69:3891-3896. 2001
- Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician. Best Practice and Research in Clinical Gastroenterology. 15:355-370. 2001
- Review article: should we kill or should we save Helicobacter pylori?. Alimentary Pharmacology and Therapeutics. 15:51-59. 2001
- Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers. Alimentary Pharmacology and Therapeutics. 15:105-113. 2001
- Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication ofHelicobacter pylori. Canadian Journal of Gastroenterology and Hepatology. 15:581-585. 2001
- Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC??)* for Helicobacter pylori Eradication. PharmacoEconomics (Auckland). 19:831-843. 2001
- Gastric Acid Secretory Response inHelicobacter pylori-Positive Patients with Duodenal Ulcer Disease. Canadian Journal of Gastroenterology and Hepatology. 15:29-39. 2001
- Ranitidine bismuth citrate: A review. Canadian Journal of Gastroenterology and Hepatology. 15:389-398. 2001
- A randomized controlled trial to assess alendronate‐associated injury of the upper gastrointestinal tract. Alimentary Pharmacology and Therapeutics. 14:1451-1457. 2000
- Helicobacter pylori and gastric cancer − the clinicians' point of view. Alimentary Pharmacology and Therapeutics. 14:48-54. 2000
- Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology. 119:631-638. 2000
- A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects. American Journal of Medicine. 109:201-206. 2000
- Multiparameter Flow Cytometric Analysis of Antibiotic Effects on Membrane Potential, Membrane Permeability, and Bacterial Counts of Staphylococcus aureus and Micrococcus luteus. Antimicrobial Agents and Chemotherapy. 44:827-834. 2000
- Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline. Alimentary Pharmacology and Therapeutics. 14:345-352. 2000
- Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis. European Journal of Gastroenterology and Hepatology. 12:257-265. 2000
- Bismuth-Based Triple Therapy with Bismuth Subcitrate, Metronidazole and Tetracycline in the Eradication ofHelicobacter pylori: A Randomised, Placebo Controlled, Double-Blind Study. Canadian Journal of Gastroenterology and Hepatology. 14:599-602. 2000
- Implications of Antibiotic Resistance in the Management ofHelicobacter pyloriInfection: CanadianHelicobacterStudy Group. Canadian Journal of Gastroenterology and Hepatology. 14:862-868. 2000
- Obscure Gastrointestinal Bleeding: An Approach to Management. Canadian Journal of Gastroenterology and Hepatology. 14:111-118. 2000
- Errata: (Canadian Journal of Gastroenterology (1999) September). Canadian Journal of Gastroenterology. 13:680. 1999
- Gastrointestinal safety profile of nabumetone: a meta-analysis. American Journal of Medicine. 107:55-61. 1999
- Introduction. American Journal of Medicine. 107:1-2. 1999
- The importance of clarithromycin dose in the management of H. pylori infection: a meta‐analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Alimentary Pharmacology and Therapeutics. 13:1693-1693. 1999
- Replication-Defective Adenovirus Infection ReducesHelicobacter felisColonization in the Mouse in a Gamma Interferon- and Interleukin-12-Dependent Manner. Infection and Immunity. 67:4539-4544. 1999
- Treatment after failure: the problem of "non-responders". Gut. 45:i40-i44. 1999
- The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta‐analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Alimentary Pharmacology and Therapeutics. 13:719-729. 1999
- Importance of pH Control in the Management of GERD. JAMA Internal Medicine. 159:649-649. 1999
- Anti‐ulcerogenic properties of endothelin receptor antagonists in the rat. Alimentary Pharmacology and Therapeutics. 13:537-544. 1999
- Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group.. Canadian Journal of Gastroenterology and Hepatology. 13:213-217. 1999
- Clarithromycin‐based triple therapies. Alimentary Pharmacology and Therapeutics. 13:437-438. 1999
- Decision-making in dyspepsia. European Journal of Gastroenterology and Hepatology. 11:223-230. 1999
- A Systematic Overview of the Use of Diary Cards, Quality-of-Life Questionnaires, and Psychometric Tests in Treatment Trials ofHelicobacter pylori-Positive and -Negative Non-Ulcer Dyspepsia. Scandinavian Journal of Gastroenterology, Supplement. 34:244-249. 1999
- Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Bioimaging. 35:55-63. 1999
- CanadianHelicobacter pyloriConsensus Conference Update: Infections in Adults. Canadian Journal of Gastroenterology. 13:213-217. 1999
- CanadianHelicobacterStudy Group Consensus Conference on the Approach toHelicobacter PyloriInfection in Children and Adolescents. Canadian Journal of Gastroenterology and Hepatology. 13:553-559. 1999
- Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease: a validation study.. Digestive Diseases and Sciences. 44:1376-1383. 1999
- Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis. PharmacoEconomics (Auckland). 16:679-697. 1999
- pH, healing rate, and symptom relief in patients with GERD.. Yale Journal of Biology and Medicine. 72:181-194. 1999
- Guidelines for the management of Helicobacter pylori infection. American Journal of Gastroenterology. 93:2330-2338. 1998
- Olestra and its gastrointestinal safety. Alimentary Pharmacology and Therapeutics. 12:1185-1200. 1998
- Review article: olestra and its gastrointestinal safety. Alimentary Pharmacology and Therapeutics. 12:1185-1200. 1998
- Treating Helicobacter pylori. JAMA Internal Medicine. 158:2396-2398. 1998
- Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 114:1169-1179. 1998
- Dose–response relationship of lansoprazole to gastric acid antisecretory effects. Alimentary Pharmacology and Therapeutics. 12:321-327. 1998
- A Canadian Physician Survey of Dyspepsia Management. Canadian Journal of Gastroenterology and Hepatology. 12:83-90. 1998
- Adding Once-Daily Omeprazole 20 mg to Metronidazole/Amoxicillin Treatment for Helicobacter pylori Gastritis: A Randomized, Double-Blind Trial Showing the Importance of Metronidazole Resistance. American Journal of Gastroenterology. 93:5-10. 1998
- Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology.. Canadian Journal of Gastroenterology. 12:31-41. 1998
- CanadianHelicobacter pyloriConsensus Conference. Canadian Journal of Gastroenterology and Hepatology. 12:31-41. 1998
- Cortical evoked responses following esophageal balloon distension and electrical stimulation in healthy volunteers.. Digestive Diseases and Sciences. 43:2558-2566. 1998
- Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.. Yale Journal of Biology and Medicine. 71:125-133. 1998
- Helicobacter pylori: From art to a science. Journal of Gastroenterology and Hepatology. 13:21-28. 1998
- Overview of Olestra: A New Fat Substitute. Canadian Journal of Gastroenterology and Hepatology. 12:193-197. 1998
- The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts. Canadian Journal of Gastroenterology and Hepatology. 12:551-556. 1998
- The case for treatment of dyspeptic patients infected with H. pylori. British Journal of Surgery. 164:6-10. 1998
- What Role Does Helicobacter pylori Play in Dyspepsia and Nonulcer Dyspepsia? Arguments For and Against H. pylori Being Associated With Dyspeptic Symptoms. Gastroenterology. 113:S67-S77. 1997
- What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms.. Gastroenterology. 113:S67-S77. 1997
- Zinc compounds combined with cyclodextrin inhibit growth of Helicobacter pylori in-vitro. Pharmaceutical Sciences. 3:483-485. 1997
- Helicobacter pylori: Corrections and comments - Response. CANADIAN MEDICAL ASSOCIATION JOURNAL. 157:1199-1199. 1997
- Review and Analysis of the Effects of Olestra, a Dietary Fat Substitute, on Gastrointestinal Function and Symptoms. Regulatory Toxicology and Pharmacology. 26:210-218. 1997
- Consensus Statement on Helicobacter pylori infection and its management.. Canadian Journal of Gastroenterology and Hepatology. 11:548. 1997
- Controversial issues in gastroesophageal reflux disease.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:87B-90B. 1997
- Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.. Gut. 41 Suppl 2:S1-S9. 1997
- The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:7B-20B. 1997
- The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion. Clinical Therapeutics. 19:1013-1023. 1997
-
R
eview: Eradication of Helicobacter pylori. Problems and recommendations. Journal of Gastroenterology and Hepatology. 12:590-598. 1997 - [Mechanism of proton pump inhibitors in the treatment of Holicobacter pylori-associated ulcers].. Zhonghua nei ke za zhi [Chinese journal of internal medicine]. 36:488-491. 1997
- Helicobacter pylori: new developments and treatments.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 156:1565-1574. 1997
- Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology. 112:1798-1810. 1997
- Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities: a promising alternative. European Journal of Gastroenterology and Hepatology. 9:521-525. 1997
- Optimizing the pharmacology of acid control in acid-related disorders - Panel discussion. American Journal of Gastroenterology. 92:S20-S21. 1997
- Peptic ulcer disease: Defining the treatment strategies in the era of Helicobacter pylori. American Journal of Gastroenterology. 92:S36-S40. 1997
- Peptic ulcer disease: Defining the treatment strategies in the era of Helicobacter pylori - Panel discussion. American Journal of Gastroenterology. 92:S41-S43. 1997
- Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.. American Journal of Gastroenterology. 92:36S-40S. 1997
- Ulcerogenesis: Integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer - Panel discussion. American Journal of Gastroenterology. 92:S14-S16. 1997
- Effects of Smoking on Cure ofHelicobacter pyloriInfection and Duodenal Uulcer Recurrence in Patients Treated with Clarithromycin and Omeprazole. Helicobacter. 2:27-31. 1997
- Modulation of Neurocardiac Function by Oesophageal Stimulation in Humans. Clinical Science. 92:167-174. 1997
- Cost effectiveness of Alternative Helicobacter pylori Eradication Strategies in the Management of Duodenal Ulcer. Canadian Journal of Gastroenterology and Hepatology. 11:323-331. 1997
- Evaluation of Salivary Antibodies to Detect Infection with Helicobacter pylori. Canadian Journal of Gastroenterology and Hepatology. 11:437-440. 1997
- Letter to the Editor [1]. Canadian Journal of Gastroenterology. 11:548. 1997
- Clinical economics review: cost‐effectiveness of treatment alternatives for gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 10:865-873. 1996
- Time to maximum effect of lansoprazole on gastric pH in normal male volunteers. Alimentary Pharmacology and Therapeutics. 10:897-904. 1996
- Why guidelines are required for the treatment of Helicobacter pylori infection in children.. Clinical and Investigative Medicine. 19:362-367. 1996
- Outcome of patients discharged from a coronary care unit with a diagnosis of "chest pain not yet diagnosed".. CANADIAN MEDICAL ASSOCIATION JOURNAL. 155:541-546. 1996
- An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis. European Journal of Pharmacology. 309:261-269. 1996
- Pathogenesis to Prescription: progress in understanding and treating Acid Related Disorders. Journal of the Royal Naval Medical Service. 82:122-133. 1996
- Eradication of Helicobacter pylori Infection. American Journal of Medicine. 100:42S-51S. 1996
- Introduction. American Journal of Medicine. 100:1S-1S. 1996
- A clinician’s view of strategies for preventing NSAID-induced gastrointestinal ulcers. Inflammopharmacology. 4:17-30. 1996
- Comparison of Omeprazole with Ranitidine for Treatment of Symptoms Associated with Gastroesophageal Reflux Disease and Uncomplicated Duodenal Ulcer. Canadian Journal of Gastroenterology and Hepatology. 10:156-162. 1996
- Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 154:49-53. 1996
- The Role ofHelicobacter pyloriin Pathogenesis: the Spectrum of Clinical Outcomes. Scandinavian Journal of Gastroenterology, Supplement. 31:3-9. 1996
- pH, healing rate and symptom relief in acid-related diseases.. Yale Journal of Biology and Medicine. 69:159-174. 1996
- Effects of non-steroidal anti-inflammatory drugs on prostaglandin h synthase isoenzyme 2 (cyclo-oxygenase 2) production by porcine gastric mucosa in organ culture. Inflammopharmacology. 3:299-310. 1995
- The efect of indornethacin‐induced gastric rnucosal injury on 24‐h intragastric acidity and plasma gastrin concentration in healthy volunteers. Alimentary Pharmacology and Therapeutics. 9:625-631. 1995
- Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. JAMA Internal Medicine. 155:1958-1964. 1995
- Helicobacter pyloriand gastric neoplasia: evolving concepts. Medical Journal of Australia. 163:253-255. 1995
- Critical issues in the pathophysiology and management of peptic ulcer disease.. European Journal of Gastroenterology and Hepatology. 7:685-699. 1995
- Preface. Journal of Clinical Gastroenterology. 20:v-v. 1995
- Relation of acupuncture and vagal gastric acid secretion.. Gut. 36:800-801. 1995
- The relationship between the control of pH and healing and symptom relief in gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 9:3-7. 1995
- A review of the Status of Omeprazole: The Handbury Workshop. Digestive Diseases and Sciences. 40:1S-2S. 1995
- Optimizing acid suppression for treatment of acid-related diseases. Digestive Diseases and Sciences. 40:24S-49S. 1995
- Helicobacter pyloriEradication: A Critical Appraisal and Current Concerns. Scandinavian Journal of Gastroenterology, Supplement. 30:73-76. 1995
- Critical Reappraisal of Mucosal Repair Mechanisms. Scandinavian Journal of Gastroenterology, Supplement. 30:28-31. 1995
- Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology. 108:65-74. 1995
- Preface. Scandinavian Journal of Gastroenterology, Supplement. 30:v-v. 1995
- The Current Role ofHelicobacter pyloriEradication in Clinical Practice. Scandinavian Journal of Gastroenterology, Supplement. 30:47-52. 1995
- Usual Therapy Improves Perianal Crohn??s Disease as Measured by a New Disease Activity Index. Journal of Clinical Gastroenterology. 20:27-32. 1995
- Sucralfate: The Bangkok review. Journal of Gastroenterology and Hepatology. 9:412-415. 1994
- Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection.. Journal of Gastroenterology. 29 Suppl 7:128-133. 1994
- NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.. Journal of Gastroenterology. 29 Suppl 7:34-38. 1994
- Aspects of the theoretical basis and clinical relevance of low acid states.. American Journal of Gastroenterology. 89:308-318. 1994
- Adenosine A1 receptors are not involved in contraction of canine gastric muscularis mucosae by adenosine analogues. European Journal of Pharmacology. 251:151-156. 1994
- Appropriate Acid Suppression for Optimal Healing of Duodenal Ulcer and Gastro-Oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology, Supplement. 29:79-82. 1994
- Helicobacter pylori: Eradication. Practical Gastroenterology. 18. 1994
- Inflammation, acid and ulcers.. Yale Journal of Biology and Medicine. 67:135-144. 1994
- The rationale of acid suppression in the treatment of acid‐related disease.. Alimentary Pharmacology and Therapeutics. 8:3-10. 1994
- Treatment Strategies for Symptom Resolution, Healing, andHelicobacter pyloriEradication in Duodenal Ulcer Patients. Scandinavian Journal of Gastroenterology, Supplement. 29:45-47. 1994
- Helicobacter pylori. European Journal of Gastroenterology and Hepatology. 5:963-968. 1993
- Helicobacter pylori infection in adolescents with eating disorders and dyspeptic symptoms. Journal of Pediatrics. 122:824-826. 1993
- Therapeutic role of dietary fibre.. Canadian Family Physician. 39:897-910. 1993
- Treatment of acute duodenal and pyloric channel ulcers with sucralfate suspension (2 g/10 ml) twice daily. European Journal of Gastroenterology and Hepatology. 5:287-292. 1993
- pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism.. American Journal of Gastroenterology. 88:481-483. 1993
- Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and helicobacter pylori associated gastritis?. Journal of Clinical Epidemiology. 46:273-279. 1993
- Cerebral-evoked potential responses following direct vagal and esophageal electrical stimulation in humans. American Journal of Physiology. 264:G486-G491. 1993
- Effects of chronic NSAIDs on gastric mucosal injury related to mucosal prostanoids, and plasma drug concentrations in human volunteers. Inflammation Research. 39:C21-C23. 1993
- Accelerated communication H1 contractile and H2 relaxant receptors in canine gastric muscularis mucosae. Life Sciences. 52:PL49-PL53. 1993
- Hp and pH: Implications for the Eradication of Helicobacter pylori. Scandinavian Journal of Gastroenterology, Supplement. 28:12-16. 1993
- Quality of Life–The Challenges Ahead. Scandinavian Journal of Gastroenterology, Supplement. 28:2-4. 1993
- Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.. American Journal of Gastroenterology. 87:1716-1727. 1992
- Validation of the different methods used in the assessment of experimental ulcers in animals. Surgical Research Communications. 13:131-134. 1992
- Mucosal damage during intestinal anaphylaxis in the rat. Digestive Diseases and Sciences. 37:1704-1708. 1992
- Effect of acupuncture on gastric acid secretion in healthy male volunteers. Digestive Diseases and Sciences. 37:1576-1582. 1992
- Effects of Chronic Left Vagal Stimulation on Visceral Vagal Function in Man. PACE - Pacing and Clinical Electrophysiology. 15:1588-1596. 1992
- Evidence of Impaired Afferent Vagal Function in Patients with Diabetes Gastroparesis. PACE - Pacing and Clinical Electrophysiology. 15:1597-1602. 1992
- The effect of acupuncture on gastrointestinal function and disorders.. American Journal of Gastroenterology. 87:1372-1381. 1992
- Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers. Clinical Pharmacology and Therapeutics. 51:415-421. 1992
- Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori.. Journal of Clinical Pathology - Clinical Molecular Pathology. 45:225-227. 1992
- Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration. Alimentary Pharmacology and Therapeutics. 6:103-111. 1992
- ACID REDUCTION BY MEDICAL OR SURGICAL-TREATMENT FOR DUODENAL-ULCER. Theoretical surgery. 7:1-5. 1992
- Acid, bacteria and the mucosal barrier: Aspiration or translocation as the cause of pneumonia?. European Journal of Gastroenterology and Hepatology. 4:881-884. 1992
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux Disease. Digestion. 51:59-67. 1992
- Introduction to Scandinavian Journal of Gastroenterology Supplement ‘Horizons in Gastroenterology’. Scandinavian Journal of Gastroenterology, Supplement. 27:1-1. 1992
- Localization and Treatment of Small and Large Bowel Bleeding. Canadian Journal of Gastroenterology and Hepatology. 6:169-175. 1992
- Progress with proton pump inhibition.. Yale Journal of Biology and Medicine. 65:649-657. 1992
- Role of T lymphocytes in intestinal mucosal injury. Digestive Diseases and Sciences. 37:33-39. 1992
- Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.. Gut. 33:118-124. 1992
- Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.. Journal of Clinical Pathology - Clinical Molecular Pathology. 44:695-697. 1991
- Treatment of peptic ulcer disease with sucralfate: A review. American Journal of Medicine. 91:S102-S106. 1991
- A PROSPECTIVE COMPARISON OF SYMPTOMS AND 5 DIAGNOSTIC-TESTS IN PATIENTS WITH HELICOBACTER-PYLORI POSITIVE AND NEGATIVE DYSPEPSIA. European Journal of Gastroenterology and Hepatology. 3:463-468. 1991
- Relationship between ulcer healing and acid suppression. Gastroenterology. 100:1482-1482. 1991
- Reply. Gastroenterology. 100:1482-1483. 1991
- Helicobacter pyloriand Gastric Acid Secretion: The Ulcer Link?. Scandinavian Journal of Gastroenterology, Supplement. 26:71-77. 1991
- A new programmable infusion pump for individual control of intragastric pH: validation and effect of ranitidine. European Journal of Gastroenterology and Hepatology. 3:9-13. 1991
- Introduction to Mechanisms of Injury and Sequelae ofHelicobacter pyloriInfection. Scandinavian Journal of Gastroenterology, Supplement. 26:vii-vii. 1991
- Neurophysiological Effects of Left Vagal Stimulation in Man. PACE - Pacing and Clinical Electrophysiology. 14:70-76. 1991
- Randomized controlled trials of the medical treatment of cirrhotic ascites. European Journal of Gastroenterology and Hepatology. 3:351-359. 1991
- What’s New in the Stomach? A Report on the World Congress of Gastroenterology. Canadian Journal of Gastroenterology and Hepatology. 5:43-46. 1991
- Acid suppression (II). The BMJ. 301:1330. 1990
- Inhibition of Helicobacter pylori by acetohydroxamic acid. The Lancet. 336:1584-1585. 1990
- Acid suppression.. The BMJ. 301:1047-1048. 1990
- The effect of naloxone on lipid-induced pyloric motor response in humans. Gastroenterology. 99:930-934. 1990
- Is there an optimal degree of acid suppression for healing of duodenal ulcers?. Gastroenterology. 99:345-351. 1990
- The risk of upper gastrointestinal haemorrhage during steroidal and non-steroidal anti-inflammatory therapy. Best Practice and Research in Clinical Rheumatology. 4:207-217. 1990
- Twenty‐four‐hour intragastric acidity and nocturnal gastric secretion in gastric ulcer patients—the effects of cimetidine. Alimentary Pharmacology and Therapeutics. 4:275-281. 1990
- 14C-urea breath test for the detection of Helicobacter pylori.. American Journal of Gastroenterology. 85:399-403. 1990
- C-14 UREA BREATH TEST FOR THE DETECTION OF HELICOBACTER-PYLORI. American Journal of Gastroenterology. 85:399-403. 1990
- MEDICAL-MANAGEMENT OF GASTROINTESTINAL-BLEEDING. European Journal of Gastroenterology and Hepatology. 2:73-78. 1990
- Control of Pepsinogen Synthesis and Secretion. Gastroenterology Clinics of North America. 19:27-40. 1990
- PEPTIC-ULCER DISEASE - PREFACE. Gastroenterology Clinics of North America. 19:R9-R12. 1990
- The relationship between suppression of acidity and gastric ulcer healing rates. Alimentary Pharmacology and Therapeutics. 4:25-33. 1990
- Acid and Barriers: Current Research and Future Developments for Peptic Ulcer Therapy. Scandinavian Journal of Gastroenterology, Supplement. 25:19-26. 1990
- Antigen-Induced Mucosal Damage and Restitution in the Small Intestine of the Immunized Rat. International Archives of Allergy and Applied Immunology. 91:270-277. 1990
- Chairman’s Introduction. Digestion. 47:1-2. 1990
- Diagnosis and treatment of gastrointestinal bleeding: When, with what and by whom?: Overview. European Journal of Gastroenterology and Hepatology. 2:69-72. 1990
- Do Hourly Averaged pH Readings Correlate with Those from Point Readings of Aspiration?. Digestive Diseases. 8:31-37. 1990
- Introduction to Scandinavian Journal of Gastroenterology Supplement ‘Horizons in Gastroenterlogy’. Scandinavian Journal of Gastroenterology, Supplement. 25:v-v. 1990
- Role of endoscopy in the diagnosis of cancer: a consensus statement prepared by a working party of the International Union against Cancer.. Cancer Research. 49:6822-6827. 1989
- A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett’s) esophagus. Gastrointestinal Endoscopy. 35:541-544. 1989
- Can Gastritis Symptoms Be Evaluated in Clinical Trials? An Overview of Treatment of Gastritis, Nonulcer Dyspepsia and Campylobacter-Associated Gastritis. Journal of Clinical Gastroenterology. 11:496-501. 1989
- Smoking and Duodenal Ulcer Disease. Journal of Clinical Gastroenterology. 11:S34-S34. 1989
- Optimization of a medium for the rapid urease test for detection of Campylobacter pylori in gastric antral biopsies. Journal of Clinical Microbiology. 27:2080-2082. 1989
- Does misoprostol given as a single large dose improve its antisecretory effect?. Alimentary Pharmacology and Therapeutics. 3:403-407. 1989
- Editorial. Journal of Clinical Gastroenterology. 11:376-378. 1989
- The effect of tripotassium dicitrato bismuthate on pepsin activity. Alimentary Pharmacology and Therapeutics. 3:381-385. 1989
- Effect of hydrochloric acid and prostaglandins on pepsinogen synthesis and secretion in canine gastric chief cell monolayer cultures.. Gut. 30:774-781. 1989
- Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.. Gut. 30:594-599. 1989
- Campylobacter pylori and trials of ulcer recurrence.. Journal of Clinical Gastroenterology. 11:237. 1989
- Initial Therapy and Relapse of Duodenal Ulcer: Possible Acid Secretory Mechanisms. Gastroenterology. 96:632-639. 1989
- ADVANCES IN ACID PEPTIC DISORDERS - PROCEEDINGS OF A SYMPOSIUM HELD DURING THE INTERNATIONAL-CONGRESS ON GASTROENTEROLOGY AND DIGESTIVE ENDOSCOPY IN ROME, ITALY, SEPTEMBER 8, 1988 - INTRODUCTION. Journal of Clinical Gastroenterology. 11:R5-R5. 1989
- Exocrine Pancreatic Function Tests: A Review. Canadian Journal of Gastroenterology and Hepatology. 3:153-161. 1989
- Introduction. Journal of Clinical Gastroenterology. 11:v. 1989
- Media for the culture of Campylobacter pylori.. American Journal of Gastroenterology. 84:79. 1989
- Relationship between Inhibition of Acid Secretion and Healing of Peptic Ulcers. Scandinavian Journal of Gastroenterology, Supplement. 24:43-47. 1989
- Validation of pH Dataloggers for Pharmacologic Studies. Scandinavian Journal of Gastroenterology, Supplement. 24:975-981. 1989
- Campylobacter pylori Infection. ACP journal club. 109:925-925. 1988
- Control of pepsinogen synthesis and secretion in primary monolayer cultures of canine gastric chief cells. Digestive Diseases and Sciences. 33:1583-1591. 1988
- Changes in rat and human pepsinogen phenotypes induced by N′-methyl-N′nitro-n-nitrosoguanidine. Cancer. 62:1958-1961. 1988
- Isolation and Partial Characterization of Gastrotropin from Canine Ileum: Further Studies of the Parietal and Chief Cell Response*. Molecular Endocrinology. 123:2578-2584. 1988
- Acid suppression and ulcer healing: dichotomy, degree, and dilemma.. American Journal of Gastroenterology. 83:964-966. 1988
- Prospective comparison of double contrast barium enema plus flexible sigmoidoscopy v colonoscopy in rectal bleeding: barium enema v colonoscopy in rectal bleeding.. Gut. 29:1188-1193. 1988
- Combination of pirenzepine and cimetidine in the therapy of duodenal ulcer.. American Journal of Gastroenterology. 83:891-892. 1988
- Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist.. Gut. 29:890-893. 1988
- H2-RECEPTOR ANTAGONIST NON-RESPONDERS. The Lancet. 332:275-275. 1988
- Medical regimens in short- and long-term ulcer management. Best Practice and Research in Clinical Gastroenterology. 2:655-676. 1988
- Effect of immunologic reactions on rat intestinal epithelium. Gastroenterology. 94:1368-1375. 1988
- Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology. 94:1130-1134. 1988
- The treatment of gastric ulcer with antisecretory drugs. Digestive Diseases and Sciences. 33:619-624. 1988
- Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease.. Clinical and Investigative Medicine. 11:151-155. 1988
- How does smoking harm the duodenum?. The BMJ. 296:864-865. 1988
- Pharmacokinetics and pharmacodynamics of treatments for peptic ulcer disease in the elderly.. American Journal of Gastroenterology. 83:211-215. 1988
- Changes in intestinal permeability and epithelial differentiation during inflammation in the rat.. Gut. 29:57-61. 1988
- Closing Remarks. Scandinavian Journal of Gastroenterology, Supplement. 23:231-232. 1988
- Panel Discussion: What is New in Etiology and Pathogenesis of Peptic Ulcer Disease?. Scandinavian Journal of Gastroenterology, Supplement. 23:225-230. 1988
- Screening and Diagnosis of Colorectal Cancer. Canadian Journal of Gastroenterology and Hepatology. 2:99-106. 1988
- The Protective Role of Gastric Acid. Scandinavian Journal of Gastroenterology, Supplement. 23:34-39. 1988
- Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.. American Journal of Gastroenterology. 82:1159-1164. 1987
- Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.. Gut. 28:1120-1127. 1987
- Management of NSAID induced gastrointestinal disturbance.. Annals of the Rheumatic Diseases. 46:640-643. 1987
- Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue. Alimentary Pharmacology and Therapeutics. 1:305-313. 1987
- PROSTAGLANDINS FOR PEPTIC ULCER DISEASE. The Lancet. 329:1262-1262. 1987
- The limitations of current therapy in peptic ulcer disease.. Clinical and Investigative Medicine. 10:171-177. 1987
- The effects of intravenous famotidine on pentagastrin‐stimulated gastric secretion in man. Alimentary Pharmacology and Therapeutics. 1:125-132. 1987
- A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.. American Journal of Gastroenterology. 82:36-41. 1987
- Relationship between gastric secretion and infection.. Gut. 28:96-107. 1987
- Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer.. Hepato-Gastroenterology: current medical and surgical trends. 33:267-270. 1986
- Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.. Gut. 27:1058-1061. 1986
- SCIENTIFIC REQUIREMENTS FOR DIAGNOSTIC-TESTS IN GASTROENTEROLOGY. Journal of Clinical Gastroenterology. 8:331-338. 1986
- Scientific Requirements for Diagnostic Tests in Gastroenterology. Journal of Clinical Gastroenterology. 8:331-338. 1986
- An alternative view of the stomach—measurement and mucosal defense. Gastrointestinal Endoscopy. 32:118-119. 1986
- THE DRUG TREATMENT OF DUODENAL ULCER: PHYSIOLOGICAL CONSIDERATIONS IN THE CHOICE OF THERAPY. Internal Medicine Journal. 16:263-267. 1986
- The value of colonoscopic brush biopsies in the assessment of recurrent carcinoma within the pelvis. Journal of the Royal Naval Medical Service. 72:26-28. 1986
- Nocturnal Gastric Acid Secretion: Its Importance in the Pathophysiology and Rational Therapy of Duodenal Ulcer. Scandinavian Journal of Gastroenterology, Supplement. 21:17-24. 1986
- Spontaneous Hypochlorhydria in Man: Possible Causes and Consequences. Digestive Diseases. 4:26-32. 1986
- The Correlation between Acid Suppression and Peptic Ulcer Healing. Scandinavian Journal of Gastroenterology, Supplement. 21:22-31. 1986
- The Effect of Temperature and pH on the Stability of Human Pepsin in Stored Gastric Juice: A Method to Prevent Activity Loss. Scandinavian Journal of Gastroenterology, Supplement. 21:650-654. 1986
- Gastric secretion in patients with typhoid.. Gut. 26:1387-1388. 1985
- Single nocturnal doses of pirenzepine effectively inhibit overnight gastric secretion.. Hepato-Gastroenterology: current medical and surgical trends. 32:240-242. 1985
- Comparison of different strategies for treating duodenal ulcer. The BMJ. 290:1904-1904. 1985
- Epidemic hypochlorhydria.. The BMJ. 290:1383-1386. 1985
- NOCTURNAL DOSES OF H2 RECEPTOR ANTAGONISTS FOR DUODENAL ULCER. The Lancet. 325:647-648. 1985
- The effect of H2-receptor antagonists on pepsin secretion in man.. Progress in Clinical and Biological Research. 173:159-167. 1985
- Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer.. Scandinavian Journal of Gastroenterology, Supplement. 19:1045-1047. 1984
- Effect of no treatment, cimetidine 1 g/day, cimetidine 2 g/day and cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders.. Gut. 25:1211-1216. 1984
- Stability of gastric-juice pepsin, and a method for its preservation.. Clinical Chemistry. 30:1582-1583. 1984
- RANITIDINE 150 mg TWICE DAILY VS 300 mg NIGHTLY IN TREATMENT OF DUODENAL ULCERS. The Lancet. 324:274-276. 1984
- Studies on the cimetidine resistant duodenal ulcer: A summary of work performed at the Royal Naval Hospital, Haslar. Journal of the Royal Naval Medical Service. 70:70-81. 1984
- Diagnostic Approach to Evaluating the Cause of a Positive Fecal Occult Blood Test. CA - A Cancer Journal for Clinicians. 34:148-157. 1984
- Cimetidine versus ranitidine for refractory Zollinger-Ellison syndrome.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 130:550-554. 1984
- The Use of a Polaroid Camera for Gastrointestinal Endoscopy. Endoscopy. 16:22-23. 1984
- H2-BLOCKERS: NIGHT-TIME ONLY. The Lancet. 322:1371-1371. 1983
- The effect of cimetidine on pepsin secretion in patients with Zollinger Ellison Syndrome. Journal of the Royal Naval Medical Service. 69:151-153. 1983
- Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.. Gut. 24:904-908. 1983
- Towards safer colonoscopy.. Gut. 24:371-375. 1983
- BLEEDING AND DIVERTICULAR DISEASE. The Lancet. 321:830-830. 1983
- Accuracy and value of the Hemoccult test in symptomatic patients.. The BMJ. 286:673-674. 1983
-
H
2 receptor antagonists - cimetidine and ranitidine. The BMJ. 286:1283. 1983 - Colonoscopic Diagnosis of Inflammatory Bowel Disease. Surgical Clinics of North America. 62:905-913. 1982
- PEPPERMINT OIL TO REDUCE COLONIC SPASM DURING ENDOSCOPY. The Lancet. 320:989-989. 1982
- ANGIODYSPLASIA OF THE COLON. The Lancet. 320:16-19. 1982
- Effect of transdermally administered hyoscine methobromide on nocturnal acid secretion in patients with duodenal ulcer.. The BMJ. 284:1736-1738. 1982
- INTRAGASTRIC ACIDITY, BACTERIA, NITRITE, AND N-NITROSO COMPOUNDS BEFORE, DURING, AND AFTER CIMETIDINE TREATMENT. The Lancet. 319:1091-1095. 1982
- Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.. Gut. 23:157-163. 1982
- Studies of intragastric acidity and nocturnal acid secretion in cimetidine nonresponders. Gastroenterology. 82:1068. 1982
- Use and abuse of H2 receptor antagonists.. Clinical Medicine. 16:33-39. 1982
- Flexible sigmoidoscopy in outpatients with suspected colonic disease. The BMJ. 283:1607-1607. 1981
- ANGIODYSPLASIA. The Lancet. 318:1340-1340. 1981
- Peptic Ulcer in the Royal Navy. Journal of the Royal Naval Medical Service. 67:125-130. 1981
- The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.. Scandinavian Journal of Gastroenterology, Supplement. 69:33-37. 1981
- Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.. Gut. 22:319-322. 1981
- Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.. Gut. 22:49-54. 1981
- Intravenous oxmetidine is a more potent inhibitor of meal-stimulated acid secretion than cimetidine. Gastroenterology. 80:1233. 1981
- SK&F 93479 is a long-acting inhibitor of gastric acid secretion in man. Gut. 22. 1981
- The 24 hour profile of intragastric PH bacterial flora and concentrations of nitrite and nitrosocompounds during cimetidine treatment. American Journal of Gastroenterology. 76:180. 1981
- The potency and duration of action of ranitidine and cimetidine on meal-stimulated acid output. Gastroenterology. 80:1311. 1981
- Oesophagitis. Journal of the Royal Naval Medical Service. 66:203-212. 1980
- Endoscopic sphincterotomy for bile duct stones. British Journal of Radiology. 53:1041-1046. 1980
- Peptic ulceration in patients with chronic liver disease. Digestive Diseases and Sciences. 25:756-760. 1980
- Massive bleeding from the large bowel.. The BMJ. 280:1320-1321. 1980
- Histamine H2Receptors and Intrinsic Factor Secretion. Scandinavian Journal of Gastroenterology, Supplement. 15:377-384. 1980
- Gastric secretory studies in humans with impromidine (SK&F 92676)—a specific histamine H2 receptor agonist. Gastroenterology. 78:505-511. 1980
- The Diagnosis and Prognosis of Upper Gastrointestinal Haemorrhage. Journal of the Royal Naval Medical Service. 66:11-14. 1980
- Comparison of the effects of SK&F 92994 and cimetidine on food stimulated gastric acid secretion. Hepato-Gastroenterology: current medical and surgical trends. 27. 1980
- Comparison of the effects on 24 H intragastric acidity of SK&F 92994 and two dose regimens of cimetidine. Hepato-Gastroenterology: current medical and surgical trends. 27. 1980
- Effects of graded doses of secretagogues on gastric secretion. Hepato-Gastroenterology: current medical and surgical trends. 27. 1980
- Gastric acid secretory responses to pentagastrin, histamine and impromidine (SK&F 92676) compared. Hepato-Gastroenterology: current medical and surgical trends. 27. 1980
- The Epidemiology and Pathogenesis of Gastric Ulcer. Frontiers of Gastrointestinal Research. 6:57-70. 1980
- Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer.. The BMJ. 1:1308-1309. 1979
- Is intrinsic factor really affected by cimetidine?. The BMJ. 1:1251-1252. 1979
- Transient Ischaemic Colitis – Colonoscopy and Biopsy in Diagnosis. Journal of the Royal Naval Medical Service. 65:5.1-19. 1979
- 1970-79, Cimetidine. Journal of pharmacotherapy. 2:24-40. 1979
- Comparisons of 24-hour intragastric acidity in duodenal ulcer patients on high dose antacid or cimetidine. Gastroenterology. 76:1204. 1979
-
Gastric secretory responses in man to a specific histamine H
2 receptor agonist. Gastroenterology. 76:1158. 1979 - The role of colonoscopy in complicated diverticular disease. A review.. Acta Chirurgica Belgica. 78:349-353. 1979
- Colonoscopy for unexplained rectal bleeding.. The BMJ. 2:1685-1687. 1978
- Rectal Bleeding. Clinics in Gastroenterology. 7:719-740. 1978
- Acquired double pylorus.. The BMJ. 1:759-759. 1978
- Reduction of intragastric acidity in duodenal ulcer. Cimetidine or surgery?. ACTA GASTRO-ENTEROLOGICA BELGICA. 41:458-462. 1978
- 24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.. Gut. 18:85-90. 1977
- Cimetidine in the treatment of gastric ulcer. EXCERPTA MEDICA,AMSTERDAM - ICS. No. 416:293. 1977
- Is intrinsic factor really affected by cimetidine?. Gut. 18. 1977
- The effects of oral cimetidine on food stimulated gastric acid secretion and 24 hour intragastric acidity. EXCERPTA MEDICA,AMSTERDAM - ICS. No. 416:189-204. 1977
- HEALING OF GASTRIC ULCER DURING TREATMENT WITH CIMETIDINE. The Lancet. 307:337-339. 1976
- T AND B LYMPHOCYTES IN BREAST CANCER STAGE RELATIONSHIP AND ABROGATION OF T-LYMPHOCYTE DEPRESSION BY ENZYME TREATMENT IN VITRO. The Lancet. 307:330-333. 1976
- 24 Hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut. 17:831. 1976
- Colonoscopy in management of colonic strictures.. The BMJ. 3:360-361. 1975
- Fibreoptic Endoscopy of the Upper Gastrointestinal Tract and its Application in the Royal Navy. Journal of the Royal Naval Medical Service. 61:4-10. 1975
- The effect of intravenous prostaglandin F2 alpha and E2 on the motility of the sigmoid colon.. Gut. 16:47-49. 1975
- Stress and the Enteron. Journal of the Royal Naval Medical Service. 60:49-51. 1974